4.8 Article

Programmed Multidrug Delivery Based on Bio-Inspired Capsule-Integrated Nanocoatings for Infected Bone Defect Treatment

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 13, Issue 10, Pages 12454-12462

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.0c20332

Keywords

self-assembly; implant nanocoating; drug delivery; anti-infection; bone regeneration; fracture; trauma

Funding

  1. Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program [W81XWH1710603, W81XWH1810203]
  2. AO Foundation
  3. West Virginia National Aeronautics and Space Administration Experimental Program to Stimulate Competitive Research (WV NASA EPSCoR)
  4. WVCTSI
  5. NIH [2U54GM104942-02, 5P20RR016477, U57GM104942, P30GM103488, P20GM109098, P20GM103434]
  6. Osteosynthesis & Trauma Care Foundation
  7. WVU PSCoR
  8. U.S. Department of Defense (DOD) [W81XWH1810203, W81XWH1710603] Funding Source: U.S. Department of Defense (DOD)

Ask authors/readers for more resources

A flower-inspired nanofilm was developed for the co-delivery of multiple drugs for trauma treatment. The nanocarriers achieved sustained and on-demand delivery of immune-tuning cytokines and growth factors, resulting in significant improvements in anti-infection and bone regeneration in treating infected rat femur fractures.
Infection and delayed wound healing are two major serious complications related to traumatic injuries and cause a significant burden to patients and society. Most currently available drug delivery materials typically carry a single drug, lack protection from drug loading, and face challenges in on-demand and precisely controlled drug release. Here, we report a flower (Cirsium arvense)inspired capsule-integrated multilayer nanofilm (FICIF), synthesized using a layer-by-layer self-assembly, for programmed multiple drug co-delivery for trauma (open fracture as an example) treatments. Our approach allows polypeptide multilayer nanofilms and innovative impregnated capsules to assemble hierarchical reservoirs with specific drug binding sites, shielding protection capability, and ordered packing structures. The resultant FICIF nanocarriers enable sustained and on-demand co-delivery of a unique immune-tuning cytokine (interleukin 12p70) and a growth factor (bone morphogenetic protein 2) in clinical use, resulting in extraordinary anti-infection (3 orders of magnitude improved bacterial killing) and bone regeneration (5 times enhanced bone healing) in treating infected rat femur fractures. The successful synthesis of these biomimetic high-performance delivery nanocoatings is expected to serve as a source of inspiration for the development of biomaterials for various clinical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available